From GlobeNewswire: 2024-03-31 11:00:00

Zealand Pharma A/S announces the total number of shares and voting rights as of March 31, 2024, following changes to its share capital due to exercise of employee warrants. The total number of shares is 62,648,011, with an equal number of voting rights. Zealand Pharma is a biotechnology company focused on peptide-based medicines, with over 10 drug candidates in clinical development. The company has partnerships with blue-chip pharma companies and commercial partnerships for its marketed products. For more information, visit www.zealandpharma.com. Contact Adam Lange, Investor Relations Officer, or Anna Krassowska, PhD, Vice President of Investor Relations & Corporate Communications.



Read more at GlobeNewswire: Total number of shares and voting rights in Zealand Pharma